Astrocytic GFAP expression increases during normal aging in many brain regions and in primary astrocyte cultures derived from aging rodent brains. As shown below, we unexpectedly found that the age-related increase of GFAP expression was suppressed in mixed glia (astrocytes + microglia). However, the agerelated increase of GFAP was observed when E18 neurons were co-cultured with mixed glia. Thus, the presence of microglia can suppress the age-related increase of GFAP, in primary cultures of astrocytes. To more broadly characterize how aging and co-culture with neurons alters glial gene expression, we profiled gene expression in mixed glia from young (3 mo) and old (24 mo) male rat cerebral cortex by Affymetrix microarray (Rat230 2.0). The majority of age changes were independent of the presence of neurons. Overall, the expression of twofold more genes increased with age than decreased with age. The minority of age changes that were either suppressed or revealed by the presence of neurons may be useful to analyze glial-neuron interaction during aging. Some in vitro changes are shared with those of aging rat hippocampus in studies from the Landfield group (Rowe et al., 2007; Kadish et al., 2009).
Introduction
Declines of human cognitive processing (crystalized and fluid intelligence) and processing speed begin by age 30 as determined from large community-based samples (McArdle et al., 2002; Finkel et al., 2007) . We have argued that inflammatory processes of normal aging with activation of astrocytes and microglia underlie these functional changes (Finch, 2010; Finch and Morgan, 2007) .
Before midlife, humans and animal models show increased astrocyte cell volume and levels of GFAP (Hansen et al., 1987; Morgan et al., 1999) , the intermediate filament of astrocytes, and increased inflammatory gene expression in astrocytes and microglia (Lucin and Wyss-Coray, 2009; Middeldorp and Hol, 2011; Salminen et al., 2011; Sparkman and Johnson, 2008; von Bernhardi et al., 2010) . Glial changes progress into later ages in both grey and white matter in many brain regions. The increased levels per cell of GFAP are due to increased rates of GFAP transcription, as shown by in situ hybridization with intron-cRNA probe (Morgan et al., 1999) .
Concurrently with glial activation, synaptic density declines in some brain regions, but without clinical-grade neurodegeneration or neuron loss. For example, in the cerebral cortex of healthy human brains aged 25-99 years, astrocyte activation increased progressively (Hansen et al., 1987) . These same brains also showed a decrease of synaptic density (immune-reactive PSD-95 terminals) and a shift to smaller sized neuronal perikarya (Masliah et al., 1993) . These reciprocal changes are definitive by age 60 and arise without changes in the total neuron density in brains that had no indication of Alzheimer disease or other neurodegenerative conditions.
We have hypothesized that glial activation during normal aging contributes to age-related synapse loss as part of a general process of neuronal atrophy that begins soon after maturation (Rozovsky et al., 2005; Finch, 2009 ). This hypothesis challenges the assumption from classical neuropathology that glial activation during normal aging is secondary to neurodegeneration. These processes begin soon after maturation in healthy humans and in long-lived rodents. Nonetheless, neuronal impairments at any age can cause activation of glia, e.g. rapid astrocyte GFAP induction results from inhibition of axonal electrical activity by tetrodotoxin (Canady et al., 1994) . Thus, we may consider that aging involves a complex set of reciprocal interactions between neurons and glia, which may begin during later stages of maturation.
To test hypotheses about the role of aging glia in neuronal atrophy, we have developed in vitro systems of glia cultured from adult rodent brains of different ages (heterochronic culture models). These models are based on the persistence of in vivo glial activation during primary cultures: enriched astrocyte cultures (<5% microglia and oligodendroglia) maintain the in vivo aging phenotype of elevated GFAP mRNA and protein per cell (astrocyte marker) (Rozovsky et al., 1998) , while mixed glia (3:1, astrocytes:microglia) 0889-1591/$ -see front matter Ó 2011 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2011.12.008
